TGFB1 and cholangiocarcinoma: M2 macrophage-derived TGFβ1, in particular, have been shown to induce EMT and drug resistance in cholangiocarcinoma cells via the atypical protein kinase C iota-mediated NF-κB signaling pathway [13].